Hyderabad-based Dr Reddy's Laboratories (DRL) posted a 9.5 per cent year-on-year (Y-o-Y) decline in its consolidated profit ...

RDY misses on earnings but beats on revenues in the fiscal second quarter. The bottom line suffers due to a one-time ...

No-moat Dr. Reddy’s reported mixed second-quarter earnings ... Reddy’s closed the nicotine therapy portfolio acquisition from Haleon. Management noted that business integration is underway ...

Indian generic drugmaker Dr Reddy's Laboratories recorded a 9.5 percent decline in its consolidated net profit after tax to ...

Until then, it will be managed by Haleon. Obviously ... Thank you once again on behalf of Dr. Reddy. Thank you. On behalf of Dr. Reddy's Laboratories Limited, that concludes this conference.

Haleon To Offload Non-Core Nicotine Therapy Business To Dr. Reddy's For Over $600M Haleon has agreed to sell its nicotine replacement therapy business outside the U.S. to Dr. Reddy's Laboratories ...

I was alarmed by a recent Star guest commentary that leveled a number of false attacks against Dr. Prasanth Reddy. The ...

HYDERABAD/BENGALURU (Reuters) -Indian generic drugmaker Dr Reddy's Laboratories' second-quarter ... Nicotinell, from Haleon in June. During the quarter, the company had charged off a debt tax ...

Dr. Reddy’s Laboratories’ (DRL ... Acquisition of NRT business from Haleon, consolidation of Sanofi’s vaccine portfolio ...